Enter multiple symbols separated by commas

AstraZeneca Fourth-Quarter Profit Up

AstraZeneca, Europe’s fourth-largest drug maker by prescription drug sales, posted a 21% rise in fourth-quarter earnings per share, compared to the last-year quarter.

AstraZeneca earned 93 cents a share in the last three months of 2006, compared with 77 cents a share in the year-ago quarter. But that was a penny below the Thomson Financial consensus estimate of 94 cents a share.

Sales in the company rose 11% for the fourth-quarter with $7.2 billion compared to $6.3 billion for the same period last year. The full-year sales for 2006 came in at $26.5 billion. That was a little better than the full-year consensus of $26 billion.

Pretax profit for the company was up 29% for the fourth-quarter at $2.1 million compared to $1.6 million for the same quarter, 2005.

The gain in profit is mainly due to restructuring activities, which included cutting around 3,000 positions, and the increasing demand for the company’s key drugs which include: Nexium, a heartburn drug; Seroquel, an antipsychotic; Symbicort, a treatment for breast cancer and Crestor, a cholesterol drug.

AstraZeneca has been under increasing pressure from generic drug competition which looks set to continue this year. Focus will now turn to the company’s strategy.

Shares in the company are trading up.

For 2007 AstraZeneca expects earnings in a range of $3.80 to $4.05 per share.

Contact U.S. News


    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

U.S. Video

  • Dr. Palmer paid $50,000 to hunt lion Cecil

    Minnesota dentist Dr. Walter Palmer was one of thousands who go to sub-Saharan Africa for trophy hunts. CNBC's Robert Frank reports Dr. Palmer said he did not know Cecil was famous or the hunt was illegal.

  • Moving fast to partner with Netflix: Marriott CEO

    Marriott International CEO, Arne Sorenson, discusses apprehension in the market, mergers, and business growth.

  • WiFi via drones

    Facebook wants to keep growing and has designed a drone that will provide Internet service in remote areas. CNBC's Julia Boorstin reports.